Skip to content

3 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Open access Oct 2026

The Efficacy and Safety of Combined Locoregional and Systemic Therapy versus Systemic Therapy Alone in Patients with Hepatocellular Carcinoma and Portal Vein Tumor Thrombosis: A Multicenter Real-World Retrospective Cohort Study

Background To compare the efficacy and safety of combined locoregional and systemic therapy vs systemic therapy alone in patients with hepatocellular carcinoma (HCC) and portal vein tumor thrombosis (PVTT). Methods This multicenter retrospective study included 337 patients with HCC and PVTT who received systemic therap...

J. Liu, Yuxuan Lin, Kong-Ying Lin et al. · 0 citations
Open access Sep 2026

Integrating Magnetic Resonance Imaging-Based Deep Learning and Radiomics to Predict Treatment Response in Hepatocellular Carcinoma Receiving Combined Systemic and Locoregional Therapies: A Multicenter Study

Abstract Background Although combining systemic and locoregional therapies has improved outcomes for hepatocellular carcinoma (HCC), identifying appropriate candidates remains challenging because no reliable tool predicts response. Methods This retrospective multicenter study enrolled 334 HCC patients who received firs...

Lu-Na Wang, Shi-Qi Zhou, Fei Li et al. · 0 citations
Open access Sep 2026

Targeting TREM2+ and TIMD4+ Macrophages Reprograms the Tumor Microenvironment and Enhances PD-1 Blockade Efficacy in Intrahepatic Cholangiocarcinoma

TREM2+ and TIMD4+ macrophages are key regulators of the immunosuppressive TME in ICC, and combining anti-Trem2 and anti-Timd4 with anti-Pd-1 antibodies significantly improved treatment outcomes in the ICC mice.

Yao Li, Hong-Wen Liu, Lei Xu et al. · 0 citations

We use cookies to run the site and, with your consent, for analytics and to show ads. See our Cookie Policy.